Table 2.
Clinical data of 12 patients who had malignancy
| Age (years) |
Sex | Diagnosis | ILD | Malignancy (n = 12) | Detected autoantibodies |
|||
|---|---|---|---|---|---|---|---|---|
| Time of detection† (months) |
Primary site |
Cancer-associated myositis |
||||||
| 1 | 56 | F | DM | - | -11 | Esophagus | Yes | Anti-p155/140 |
| 2 | 46 | F | DM | - | +18 | Breast | Yes | Anti-Mi2 |
| 3 | 59 | M | DM | - | -1 | Stomach | Yes | Anti-p155/140 |
| 4 | 53 | F | DM | - | 0 | Lung | Yes | Anti-p155/140 |
| 5 | 74 | F | PM/SLE | + | - 48 | Stomach | No | Anti-PL-7 |
| 6 | 57 | M | PM | - | 0 | Liver | Yes | none |
| 7 | 36 | F | DM/SLE | + | -1 | Thyroid | Yes | Anti-PL-12 |
| 8 | 36 | M | DM | - | 0 | Lymphoma | Yes | Anti-p155/140 |
| 9 | 50 | F | DM | - | -2 | Breast | Yes | Anti-p155/140 |
| 10 | 61 | M | DM | + | +22 | Lymphoma | Yes | Anti-Jo-1 |
| 11 | 68 | M | DM | - | +2 | Lung | Yes | none |
| 12 | 65 | M | PM | + | 0 | Stomach | Yes | Anti-Jo-1 |
† Relative to time of myositis diagnosis.
DM = dermatomyositis, F = female, ILD = interstitial lung disease, M = male, PM = polymyositis, SLE = systemic lupus erythematosus